Joanne L Mitchell
Overview
Explore the profile of Joanne L Mitchell including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
474
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bye A, Kriek N, Kempster C, Dunster J, Mitchell J, Sage T, et al.
Circ Res
. 2025 Jan;
136(4):439-441.
PMID: 39840431
No abstract available.
2.
AlOmar S, Mitchell J, AlZahrani E
Thromb J
. 2024 Dec;
22(1):108.
PMID: 39639307
No abstract available.
3.
AlOmar S, Mitchell J, AlZahrani E
Thromb J
. 2024 Apr;
22(1):39.
PMID: 38654303
Formyl peptide receptors (FPRs) are members of seven transmembrane G protein-coupled receptors superfamily that exhibit different responses based on the nature of stimulating ligand type. FPRs have been shown to...
4.
Bozbas E, Zhou R, Soyama S, Allen-Redpath K, Mitchell J, Fisk H, et al.
Am J Clin Nutr
. 2024 Mar;
119(5):1175-1186.
PMID: 38484976
Background: Extracellular vesicles (EVs) are proposed to play a role in the development of cardiovascular diseases (CVDs) and are considered emerging markers of CVDs. n-3 PUFAs are abundant in oily...
5.
Mitchell J, Khan D, Rana R, Kriek N, Unsworth A, Sage T, et al.
Platelets
. 2023 Oct;
34(1):2264940.
PMID: 37822056
Multiple myeloma (MM) and its precursor states, smoldering myeloma (SM) and monoclonal gammopathy of undetermined significance (MGUS) are associated with increased incidence of thrombosis, however the cause of this is...
6.
El-Awaisi J, Mitchell J, Ranasinghe A, Kalia N
Front Cardiovasc Med
. 2023 Sep;
10:1227499.
PMID: 37753164
Aims: Risks and outcomes of myocardial infarction (MI) are different between men and women and some studies have demonstrated that the latter have a higher risk of mortality. Whilst there...
7.
Mitchell J, Little G, Bye A, Gaspar R, Unsworth A, Kriek N, et al.
Res Pract Thromb Haemost
. 2023 Aug;
7(5):100200.
PMID: 37601014
Background: Factor XIII (FXIII) is an important proenzyme in the hemostatic system. The plasma-derived enzyme activated FXIII cross-links fibrin fibers within thrombi to increase their mechanical strength and cross-links fibrin...
8.
Mitchell J, Dunster J, Kriek N, Unsworth A, Sage T, Mohammed Y, et al.
J Thromb Haemost
. 2023 Apr;
21(8):2248-2259.
PMID: 37085037
Background: The response of platelets to activating stimuli and pharmaceutical agents varies greatly within the normal population. Current platelet function tests are used to measure end-point levels of platelet activation...
9.
Kriek N, Nock S, Sage T, Khalifa B, Bye A, Mitchell J, et al.
Thromb Haemost
. 2022 Mar;
122(7):1115-1129.
PMID: 35253142
Cucurbitacins are dietary compounds that have been shown to elicit a range of anti-tumour, anti-inflammatory and anti-atherosclerotic activities. Originally identified as signal transducer and activator of transcription, STAT, inhibitors, a...
10.
Dunster J, Bye A, Kriek N, Sage T, Mitchell J, Kempster C, et al.
Blood Adv
. 2021 Sep;
5(20):4017-4030.
PMID: 34474473
Accurate and comprehensive assessment of platelet function across cohorts of donors may be key to understanding the risk of thrombotic events associated with cardiovascular disease, and, hence, to help personalize...